In squamous cell carcinomas of the head and neck (HNSCC), triggering the TLR3 signaling pathway along with cisplatin induces production of the proinflammatory cytokines IFN-β, IL-6, and CCL5 to promote cellular survival (39). The gene discussed is TLR3; the disease is head and neck squamous cell carcinoma.